NEW YORK (GenomeWeb News) – Lipomics Technologies today said that it is collaborating with the Joslin Diabetes Center on two studies, one of which aims to identify biomarkers for potential diagnostics.
The first study, on insulin-resistant patients with a family history of type 2 diabetes, aims to identify predictive markers of diabetes that Lipomics could develop into blood-based diagnostics. The second study will focus on the effects of gastric bypass surgery on insulin sensitivity.
West Sacramento, Calif.-based Lipomics said it will retain certain rights to develop diagnostics based on data that emerges from the two studies.
Other details of the agreement were not disclosed.